新型藤黄酸衍生物的合成及其抗肿瘤活性

以藤黄酸(1)为原料,分别与HBr和有机胺反应,合成了9个新型的藤黄酸衍生物(2~6),其结构经1HNMR,MS和HR-MS表征。采用MTT法测定了2~6对人结肠腺癌细胞(RKO)、人肝癌细胞(HepG-2)和人卵巢腺癌细胞(OVCAR-3)的体外抗肿瘤活性。结果表明,藤黄酸(N-丙基对甲苯磺酰胺)酯3,藤黄酸(N-丙基苯丙酰胺)酯4和N-色胺藤黄酰胺6b的抗肿瘤活性显著高于1;33-羟基转位藤黄酸2的抗肿瘤活性则大大降低。     

新型芳基修饰的藤黄酸衍生物的合成及其抗肿瘤活性

以取代酚或羟基吡啶为原料,在无水碳酸钾存在下,与溴代醇发生威廉姆森醚合反应制得中间体--芳（杂环）氧基醇(2a~2k); 2a~2k分别与藤黄酸通过光延反应合成了藤黄酸衍生物（3a~3k）。以DDC/HOSu为偶联剂,芳酸与3-氨基-1-丙醇经偶联反应制得中间体--芳酰氨基醇（5a~5h）; 5a~5h分别与藤黄酸通过光延反应合成了藤黄酸衍生物（6a~6h）。 2, 3, 5和6为新化合物,其结构经¹H NMR, ESI-MS和HR-MS表征。采用MTT法测定了3和6对肺腺癌细胞(A549)、肝癌细胞(HepG-2)和乳腺癌细胞(SK-BR-3)的体外抗肿瘤活性。结果表明：部分化合物对肿瘤细胞的抑制活性明显高于藤黄酸。     

新型藤黄酸衍生物的合成

以藤黄酸为原料,经酯化得藤黄酸甲酯(2);通过对2的6-位酚羟基进行结构修饰,合成了5个新型的藤黄酸衍生物,其结构经1H NMR和IR表征。     

微管蛋白聚合抑制剂OXi8006的合成新方法

2-(3'-羟基-4'-甲氧基苯基)-3-(3",4",5"-三甲氧基苯甲酰基)-6-甲氧基吲哚(OXi8006)能够有效抑制微管蛋白聚合,而表现出良好抗癌活性.目前报道的OXi8006全合成路线较长、总收率低,且反应条件苛刻.为了更高效地合成该化合物,从而为进一步的活性和构效关系研究提供原料.以廉价易得的异香兰素为起始原料,先合成芳基乙炔,再与3,4,5-三甲氧基苯甲醛通过亲核加成、氧化反应获得二芳基炔酮、二芳基炔酮再与邻碘代苯胺通过杂迈克尔加成和分子内Heck反应构建出OXi8006的主体结构——2-芳基-3-芳酰基取代吲哚,从而缩短了合成路线,并使总收率提高到20%.     

天然产物Combretastatin A-1和Combretastatin B-1的合成

基于Perkin反应策略合成了具有强效抗肿瘤、抗血管活性的天然产物Combretastatin A-1(CA1)和Combretastatin B-1(CB1).以2,3,4-三羟基苯甲醛(1)为起始物, 经单甲基化反应得到2,3-二羟基-4-甲氧基苯甲醛(2), 再经酚羟基保护得到2,3-二异丙基-4-甲氧基苯甲醛(3), 该化合物与3,4,5-三甲氧基苯乙酸(4)发生Perkin反应分离得到E-2-(3,4,5-三甲氧基苯基)-3-(2',3'-二异丙氧基-4'-甲氧基)丙烯酸(E-5), 经脱羧反应得到Z-3,4,4',5-四甲氧基-2',3'-二异丙氧基二苯乙烯(6), 最后经脱保护反应得到CA1.另外, 将E-2-(3,4,5-三甲氧基苯基)-3-(2',3'-二异丙氧基-4'-甲氧基)丙烯酸(E-5)脱去保护基得到E-2-(3,4,5-三甲氧基苯基)-3-(2',3'-二羟基-4'-甲氧基)丙烯酸(7), 该化合物经脱羧-异构化反应得到E-3,4,4',5-四甲氧基-2',3'-二羟基二苯乙烯(E-CA1), 最后经催化氢化得到CB1.     

Ⅴ.β-(2-甲基-7-甲氧基-1,2,3,4,9,10,11,12-八氢化-1-亚菲基)-丙酸的合成

由1-氧代-2-甲基7-甲氧基-1,2,3,4,9,10,11,12-八氢化菲及溴代乙酸甲酯的Re-formatsky反应,得到1-羟基-2-甲基-7-甲氧基-1,2,3,4,9,10,11,12-八氢化菲-1-乙酸甲酯。由此羟基酯与二硫亚砜及吡啶的反应后,得(2-甲基-7-甲氧基1,2,3,4,9,10,11,12-八氢化-1-亚菲基)-乙酸甲酯。此酯经过水解后,得到相对应的酸,此酸酰氯经过Arndt- Eistert在甲醇内的反应,得到β-(2-甲基-7-甲氧基-1,2,3,4,9,10,11,12-八氢化-1-亚菲基)-丙酸甲醇。此酯经过水解后,得到相对应的酸。     

1,3,4-噁二唑和1,3,4-噻二唑衍生物的设计、合成和生物活性研究

为了寻求新型抗肿瘤药物,设计并合成了一系列新型1,3,4-噁二唑和1,3,4-噻二唑衍生物,对这些化合物在人类四种癌细胞:B-16(皮肤黑色素瘤细胞)、PC-3(人前列腺癌细胞)、U87(人原发性胶质母细胞瘤细胞)和A549(人非小细胞肺癌细胞)进行抗肿瘤活性评价.结果显示部分化合物具有较好的抗肿瘤活性,尤其是5-{6-[4-(2-羟基乙基)哌嗪-1-基]-2-甲基嘧啶-4-基氨基}-[1,3,4-噻二唑-2-羧酸(2-甲氧基苯基)酰胺(8b)和5-{6-[4-(2-羟基乙基)哌嗪-1-基]-2-甲基嘧啶-4-基氨基}-[1,3,4-噻二唑-2-羧酸(4-甲氧基苯基)酰胺(8c),对四种癌细胞都显示出较高的抗肿瘤活性,其抑制活性均优于阳性对照达沙替尼.随后对这类化合物抑制肿瘤的可能靶点开展了进一步研究.     

海南染木树叶中的蒽醌成分研究

从海南染木树叶乙醇提取物的乙酸乙酯萃取部位分离得到9个蒽醌类化合物,采用高分辨质谱、一维和二维核磁共振等现代波谱技术,鉴定上述化合物的结构分别为:7-羟基-1,2-二甲氧基-6-甲基-9,10-蒽醌(1),1-羟基-3,6-二甲氧基-9,10-蒽醌(2),10,10'-二蒽酮(3),9,10-蒽醌(4),甲基异茜草素(5),虎刺醇(6),2-羟基-3-甲基-9,10-蒽醌(7),3-羟基-1,2-二甲氧基-9,10-蒽醌(8)和3-羟基-1-甲氧基-2-甲酯基-9,10-蒽醌(9).其中化合物1和2为新天然产物,且化合物1的波谱数据迄今未见任何报道.除化合物9外,其余化合物均为首次从该属植物中分离得到.抗菌活性测试显示,化合物2和9对多种菌株具有很好的抑制作用,尤其是金黄色葡萄球菌,最小抑菌浓度(MIC)值均达到0.078μg/mL;化合物1和6对枯草芽孢杆菌、金黄色葡萄球菌显示出与阳性对照环丙沙星相当或者更强的抑制活性.     

白芍中一种内生真菌Penicillium mariae-crucis的次生代谢产物研究

综合运用多种现代色谱学分离方法对白芍中内生真菌Penicilliummariae-crucis的次生代谢产物进行了研究,从其发酵液的乙酸乙酯萃取部位中分离得到了10个化合物,采用多种现代波谱技术确定了这些化合物的化学结构,分别鉴定为:penicmariae-crucis A (1)、penicmariae-crucis B (2)、penicmariae-crucis C (3)、penicmariae-crucis D (4)、(E)-2-甲基己-3-烯二酸(5)、2-乙酰基-3-羟基-5-甲氧基苯乙酸(6)、2-乙酰基-3-羟基-5-甲氧基苯乙酸甲酯(7)、2-乙酰基-3,5-二羟基苯乙酸甲酯(8)、β-谷甾醇(9)、过氧化麦角甾醇(10);其中化合物1～4为新化合物,化合物5为新天然产物,所有化合物均为首次从内生真菌P. mariae-crucis中分离得到.     

藤黄酸氰基衍生物的合成及抗肿瘤活性

以藤黄酸为原料,经过酯化反应或酰胺化反应,在C-30位的羧基上引入不同的烷氰基或芳香氰基,设计合成了7个藤黄酸氰基衍生物,其中6个为新化合物,其结构经MS和¹H NMR确证。 采用四氮唑蓝(MTT)法测试了合成化合物对肝癌细胞(HepG2)、结肠腺癌细胞(RKO)和卵巢腺癌细胞(OVCAR-3)的体外抗肿瘤活性,结果表明,所合成的化合物均具有一定的抗肿瘤活性,其中化合物4和6的抗肿瘤活性明显优于阳性对照物藤黄酸。     

α-Glucosidase inhibitory constituents from Acanthopanax senticosus harm leaves

A new triterpene glycoside, 3-O-[(α-L-rhamnopyranosyl)(1→2)]-[β-D-glucuronopyranosyl-6-O-methyl ester]-olean-12-ene-28-olic acid (1) and a new indole alkaloid, 5-methoxy-2-oxoindolin-3-acetic acid methyl ester (5) were isolated from the leaves of Acanthopanax senticosus Harms along with six known compounds. The structures of the new compounds were determined by means of 2D-NMR experiments and chemical methods. All the isolated compounds were evaluated for their glycosidase inhibition activities and compound 6 showed significant α-glucosidase inhibition activity.     

新型2-取代嘧啶酮-5-甲酰苄胺的合成及抗肿瘤生物活性试验

以丙二酸单甲酯单甲酰氯、苄胺为起始原料,经与DMF-DMA反应后形成的关键中间体分别与胍或脒缩合关环,合成了2-取代嘧啶酮-5-甲酰苄胺化合物6和7。产物经1HNMR、13CNMR、MS、HRMS进行了结构表征。初步的生物活性试验显示化合物6和7具有抗肿瘤活性。     

丁酸氯维地平降解杂质的合成

以4-(2,3-二氯苯基)-1,4-二氢-2,6-二甲基-3,5-吡啶二羧酸(2-氰基乙基)（甲基）酯(5)为起始原料,合成了丁酸氯维地平的5种降解杂质：4-(2,3-二氯苯基)-1,4-二氢-2,6-二甲基-3,5-吡啶二羧酸单甲酯(A), 4-(2,3-二氯苯基)-1,4-二氢-2,6-二甲基-3-吡啶羧酸甲酯(B), 4-(2,3-二氯苯基)-2,6-二甲基-3,5-吡啶二羧酸单甲酯(C), 4-(2,3-二氯苯基)-2,6-二甲基-3,5-吡啶二羧酸（丁酰氧基甲基）（甲基）酯(D)和4-(2,3-二氯苯基)-2,6-二甲基-3-吡啶羧酸甲酯(E)。其中A由5水解制得;B由A脱羧制得;C由5氧化后再经水解制得;D由C和丁酸氯甲酯缩合制得;E由C脱羧制得,化合物结构经¹H NMR和MS（ESI）确证。     

Synthesis of new penicillin derivatives as drug-like molecules for biological screening

Chemical modification of penicillin β-lactam ring was made.Six thiazolidine amides were produced through N4-C7 β-lactam ring opening of penicillin V methyl ester with various aliphatic,aromatic,and heterocyclic primary amines.Five 8-hydroxypenillic acid derivatives with side chains of methyl,propyl,benzyl,and diethylaminoethyl groups were yielded via β-lactam ring rearrangement from6-aminopenicillanic acid(6-APA).Parallel synthetic methods were used for the alkylation of8-hydroxypenillic acid and β-lactam ring opening of penicillin V methyl ester.The biological activities of the compounds were evaluated.     

氢氧化锂存在下(焦)脱镁叶绿酸-a甲酯的空气重排反应

在氢氧化锂存在下, 脱镁叶绿酸-a甲酯(1a)发生空气氧化和重排反应, 经盐酸酸化和重氮甲烷甲基化, 得到由紫红素-7三甲酯(2)、紫红素-18甲酯(3)、卟吩-p₆三甲酯(4)、地质卟啉衍生物(5)和3-环氧乙基-3-去乙烯基紫红素-18甲酯(6)所组成的混合物. 用相同的方法处理焦脱镁叶绿酸-a甲酯(1b), 则分离出13²-氧代焦脱镁叶绿酸-a甲酯(7)、15-甲酰基紫红素-5二甲酯(8)、紫红素-18甲酯(3)和3-环氧乙基-3-去乙烯基紫红素-18甲酯(6). 所得新叶绿素衍生物5, 6和8的化学结构均经UV, IR, ¹H NMR及元素分析得以证实, 并对相应的反应提出可能的反应机理.     

Antioxidant iridoid glucosides from Wendlandia formosana

Two new iridoid glucosides of 10-O-caffeoyl scandoside methyl ester (3), and 6-methoxy scandoside methyl ester (4) besides the known compounds of scandoside methyl ester (1), methyl deacetyl asperulosidate (2), 10-O-caffeoyl daphylloside (5), phytol (6), and ursolic acid (7) were isolated from the leaves of Wendlandia formosana. Structure elucidation of the new iridoid glucosides was based on interpretation of high-resolution 1D and 2D NMR spectral data and chemical conversions. Antioxidant activity of Compounds (1-5) against diphenylpicrylhydrazyl (DPPH) and hydroxyl radical, and peroxynitrite was reported.     

Phenolic compounds from Scorzonera latifolia (Fisch. & Mey.) DC

A new 3-benzylphthalide, scorzoveratrin 4'-O-β-glucoside (1), together with the known 3-benzylphthalides, scorzoveratrin (2) and scorzoveratrozit (3), the caffeoyl derivatives, chlorogenic acid methyl ester (4), 4,5-dicaffeoylquinic acid (5), 4,5-dicaffeoylquinic acid methyl ester (6), 3,5-dicaffeoylquinic acid (7) and caffeic acid (8) were isolated from the subaerial parts of Scorzonera latifolia (Fisch. & Mey.) DC. All secondary metabolites were assigned using physicochemical and spectroscopic data. The known compounds 2-8 were isolated for the first time from this species.     

Spectroscopic and theoretical studies of derivatives of 1,6- and 1,7-naphthyridines

The solvatochromism in 8-hydroxy-1,6-naphthyridin-5(6H)-one-7-carboxylic acid methyl ester (1), 5-hydroxy-1,7-naphthyridin-8(7H)-one-6-carboxylic acid methyl ester (2), and 4-hydroxy-2-methyl-1(2H)-isoquinolone-3-carboxylic acid methyl ester (3), has been studied in solvents of different polarity and hydrogen bond donor (HBD) and hydrogen bond acceptor (HBA) ability. The relative stabilities of isomers for these naphthyridine derivatives and their interaction with the solvent are reported. Two intramolecular hydrogen-bonded structures contribute to the ground state of compound 1. Temperature effects on the absorption bands were recorded to analyse the possible equilibrium between covalent and zwitterionic forms. The formation of zwitterionic species was observed only in HBD solvents, from which is inferred the solvent assistance in the proton transference. AM1 and PM3 semi-empirical calculations were used in support of the proposed interpretations.     

Ergoline derivatives—XIV : Synthesis of clavine alkaloids

The treatment of methyl lysergate with mercuric acetate in methanol yields, instead of the expected 10 - methoxy - 6 - methyl - ergoline - 8 β - carboxylic acid methyl ester (2), 10 - methoxy - 8,9 - didehydro - 6 - methyl - ergoline - 8 - carboxylic acid methyl ester (3), whose structure is demonstrated. From 3, penniclavine (14) and isosetoclavine (15) were prepared according to Scheme 1.     

On the isomerization of ent-kaurenic acid

Kaurenic acid (1a) is a tetracyclic diterpene that has an exocyclic double bond at delta16. Isokaurenic acid (2a) has an endocyclic delta15double bond. This compound has been isolated from Espeletia tenore (Espeletinae), a resinous plant from the Venezuelan Andes, but its occurrence is rare. In order to obtain a larger amount of 2a, the isomerization of la, which is easily obtained from other Espeletinae, was tried. Kaurenic acid methyl ester (1b) was treated with dil. HCl in CH3Cl/EtOH, after 6 h under reflux a yield of 41.5% isokaurenic acid methyl ester (2b) was obtained but 35.7% 16alpha-ethoxy-kauran-19-oic acid methyl ester (3b) had formed as a byproduct. Treating 1b with CF3COOH in refluxing CH2Cl2 permitted to obtain a yield of 66.6% of 2b in 4 h and only traces of 16alpha-hydroxy-kauran-19-oic acid methyl ester (3a) as a byproduct. Both isomers were separated on a silica gel column impregnated with 20% AgNO3. Treating 2b with KOH in refluxing DMSO yielded pure isokaurenic acid, no back isomerization was observed.